Two Sigma Advisers’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-158,400
| Closed | -$193K | – | 2329 |
|
|
2024
Q2 | $193K | Buy |
158,400
+11,600
| +8% | +$14.2K | ﹤0.01% | 2225 |
|
|
2024
Q1 | $320K | Buy |
146,800
+105,600
| +256% | +$230K | ﹤0.01% | 2048 |
|
|
2023
Q4 | $63.9K | Sell |
41,200
-66,700
| -62% | -$103K | ﹤0.01% | 2377 |
|
|
2023
Q3 | $139K | Sell |
107,900
-121,500
| -53% | -$157K | ﹤0.01% | 2161 |
|
|
2023
Q2 | $395K | Sell |
229,400
-286,700
| -56% | -$493K | ﹤0.01% | 1894 |
|
|
2023
Q1 | $779K | Sell |
516,100
-8,800
| -2% | -$13.3K | ﹤0.01% | 1759 |
|
|
2022
Q4 | $840K | Sell |
524,900
-2,500
| -0.5% | -$4K | ﹤0.01% | 1649 |
|
|
2022
Q3 | $765K | Buy |
527,400
+140,400
| +36% | +$204K | ﹤0.01% | 1658 |
|
|
2022
Q2 | $708K | Buy |
387,000
+38,700
| +11% | +$70.8K | ﹤0.01% | 1766 |
|
|
2022
Q1 | $930K | Buy |
348,300
+146,700
| +73% | +$392K | ﹤0.01% | 1676 |
|
|
2021
Q4 | $873K | Buy |
201,600
+400
| +0.2% | +$1.73K | ﹤0.01% | 1630 |
|
|
2021
Q3 | $1.02M | Sell |
201,200
-167,900
| -45% | -$855K | ﹤0.01% | 1610 |
|
|
2021
Q2 | $2.34M | Sell |
369,100
-281,800
| -43% | -$1.78M | 0.01% | 1220 |
|
|
2021
Q1 | $5.03M | Sell |
650,900
-42,000
| -6% | -$325K | 0.01% | 847 |
|
|
2020
Q4 | $4.54M | Buy |
692,900
+138,800
| +25% | +$909K | 0.01% | 866 |
|
|
2020
Q3 | $3.69M | Buy |
554,100
+12,300
| +2% | +$81.8K | 0.01% | 877 |
|
|
2020
Q2 | $4.51M | Buy |
541,800
+54,100
| +11% | +$451K | 0.01% | 840 |
|
|
2020
Q1 | $3.74M | Buy |
487,700
+7,600
| +2% | +$58.3K | 0.01% | 825 |
|
|
2019
Q4 | $3.99M | Buy |
480,100
+245,200
| +104% | +$2.04M | 0.01% | 937 |
|
|
2019
Q3 | $1.73M | Sell |
234,900
-18,300
| -7% | -$135K | ﹤0.01% | 1172 |
|
|
2019
Q2 | $2.84M | Buy |
253,200
+2,100
| +0.8% | +$23.6K | 0.01% | 1055 |
|
|
2019
Q1 | $2.7M | Sell |
251,100
-3,000
| -1% | -$32.2K | 0.01% | 1092 |
|
|
2018
Q4 | $3.84M | Sell |
254,100
-10,800
| -4% | -$163K | 0.01% | 901 |
|
|
2018
Q3 | $4.9M | Sell |
264,900
-9,200
| -3% | -$170K | 0.01% | 830 |
|
|
2018
Q2 | $6.27M | Buy |
274,100
+85,300
| +45% | +$1.95M | 0.02% | 760 |
|
|
2018
Q1 | $5.37M | Buy |
188,800
+66,700
| +55% | +$1.9M | 0.01% | 821 |
|
|
2017
Q4 | $2.58M | Buy |
122,100
+69,200
| +131% | +$1.46M | 0.01% | 1129 |
|
|
2017
Q3 | $961K | Buy |
+52,900
| New | +$961K | ﹤0.01% | 1490 |
|